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Abstract
Human cadavers constitute very useful educational tools to teach 
anatomy in medical scholarship and related disciplines such as 
physiology, for example. However, as biological material, human 
body is subjected to decay. Thanatopraxy cares such as embalming 
have been developed to slow down and inhibit this decay, but the 
formula used for the preservation fluids are mainly formaldehyde 
(FA)‐based. Very recently, other formulas were developed in order to 
replace FA, and to avoid its toxicity leading to important 
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environmental and professional exposure concerns. However, these 
alternative FA‐free fluids are still not validated or commercialized, 
and their efficiency is still under discussion. In this context, the use 
of FA‐releasing substances, already used in the cosmetics industry, 
may offer interesting alternatives in order to reduce professional 
exposures to FA. Simultaneously, the preservation of the body is still 
guaranteed by FA generated over time from FA‐releasers. The aim of 
this review is to revaluate the use of FA in thanatopraxy cares, to 
present its benefits and disadvantages, and finally to propose an 
alternative to reduce FA professional exposure during thanatopraxy 
cares thanks to FA‐releasers use.
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Introduction
Within the university course of medical education and related 
disciplines, human bodies are used as educational tools to teach 
students, either by prosected specimens presentation or by whole body 
dissection.
However, in recent years, several concerns have arisen concerning the 
use of the human cadaver as an educational tool. The arguments against 
dissection include ethical and financial issues, fears of health hazards, 
and awareness of people's sensitivities and religious beliefs (Brenner, 
2014). Moreover, at the time of virtualization, the imaging tools and 
practices can offer many alternatives (post mortem computed 
tomography, post mortem angiography, post mortem magnetic 
resonance imaging; Grabherr et al. 2017). On the other hand, there are 
also an increasing number of clinicians arguing for re‐enhancing 
anatomical education by dissection, because tissue resistance, texture 
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and mechanical properties cannot be mimicked by artificial models 
(Korf et al. 2008; Balta et al. 2017). As result, virtual models and real 
human cadavers from donations to medical sciences must co‐exist and 
constitute complementary tools for anatomy and morphology teaching.
However, the use of human bodies as an educational tool requires an 
appropriate preservation of the cadaver. This is achieved by treating it 
using thanatopraxy cares with special chemicals, for example, 
embalming. Embalming practices have been known since antiquity, and 
were developed mainly for religious reasons (Ancient Egypt culture, for 
example). These practices were very numerous and embalmer‐
dependent, which is still the case nowadays (Brenner, 2014; Hambly, 
2016; Balta et al. 2019). From this important cultural diversity, a huge 
variability in embalming fluids has been noticed. One of the most 
important chemicals used for body preservation is formaldehyde (FA; 
Musial et al. 2016).
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However, the toxicity of FA for practitioners and for the environment is 
well established (Duong et al. 2011; Waschke et al. 2019). 
Consequently, there is an increasing opposition to FA and other 
chemicals, whereas ‘green chemistry’ is promoted (Rocha Ferreira et al. 
2017). Recently, anatomists and embalmers tried to develop FA‐free 
preservation fluids with mixed results (Balta et al. 2015). In this 
context, the use of FA‐releasers may offer a satisfactory alternative 
from a professional exposure point of view (Van Dam, 2003; Dissard 
et al. 2010, 2018). There are over 30 FA‐releasers with a wide array of 
applications. Most are used as preservatives in cosmetics, as 
antimicrobials in metalworking fluids, paint, lacquers and varnishes, or 
as durable press chemical finishes in textiles (De Groot et al. 2009). FA 
appears as a decomposition product of a precursor already containing 
FA in its composition, or through reaction between reagents with FA as 
by‐product.
The aim of this review is to reevaluate the use of FA in thanatopraxy 
cares, to present its benefits and disadvantages, and finally to propose 
an alternative to reduce FA professional exposure during thanatopraxy 
cares thanks to use of FA‐releasers.
Materials and methods
PubMed was searched from September to December 2018 using the 
keywords ‘embalming’ AND ‘formaldehyde’ OR ‘formaldehyde 
releaser’, resulting in 155 hits. All the articles and studies that were not 
directly linked to FA reduction in human embalming cares or FA‐
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releasers were excluded. The search was therefore extended to engines 
such as Google in order to enlarge the inclusion of relevant documents 
(books, open access, European legislation).
FA in embalming fluids
Thanatopraxy refers to the art, the science or the modern techniques 
allowing the preservation of human cadavers from decomposition by the 
destruction of pathogenic microorganisms, in order to present them with 
a living appearance for public and private viewing for the funeral. As 
result, thanatopraxy refers to cold storages (positive or freezing) or to 
injections of chemicals (biocides and preservatives). These treatments 
are used to prepare the body for funeral or to store the body for further 
use as an educational tool. In this context, embalming constitutes a 
subcategory of thanatopraxy cares and is rather used to define the old 
processes used for preserving human bodies in cross‐cultural histories 
through the ages (Trompette & Lemonnier, 2009). For example, 
embalming in Ancient Egypt was a step of the mummification process, 
including evisceration, exsanguination, drying and balms, oils 
administrations before bandages wrapping (Singh Batra et al. 2010). 
Today, embalming is used to define the perfusion of the body by 
embalming fluids during thanatopraxy operations.
AQ7
The three goals of thanatopraxy are sanitization, presentation and 
preservation. Sanitization and preservation are achieved by the use of 
embalming fluids, whereas presentation is made thanks to mortuary 
cares including post mortem grooming and make‐up.
Typical modern embalming fluids contain a variety of preservatives, 
biocides, moisturizing agents and dyes. The compositions are very 
diverse and should conform with the aims of embalming: thorough and 
complete preservation; softness of tissues, colour of muscles and organs 
as in unembalmed bodies; distension (and the colouring) of the 
vasculature (Brenner, 2014). The final formulated fluid must answer to 
the biological and physicochemical properties and characteristics 
compiled in Fig. 1.
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Properties and characteristics of embalming fluid.
To achieve these goals and thanks to the bactericidal, fungicidal and 
insecticidal properties of FA, preservation with FA‐based fluids 
constituted since the beginning of 1900s the best alternative to 
dangerous and toxic concoctions of heavy metal salts.
Formaldehyde, CH O, is a highly reactive aldehyde gas formed by 
oxidation or incomplete combustion of organic material, and can be 
produced secondarily in air from photochemical reactions. FA is known 
to react with proteins, lipids and nucleic acids (Srinivasan et al. 2002; 
Hoffman et al. 2015).The properties of FA as tissue fixative and 
preservative come from these reactions and generated by‐products.
FA as tissue fixative
Formaldehyde acts by amino formylation, i.e. cross‐linking several 
proteins chemically by inserting a methylene bridge (‐CH ‐) between 
the nitrogen atoms of adjacent proteins, amines and related 
nucleophiles, resulting in fixation or tanning type action (Bedino, 2003; 
Thavarajah et al. 2012). Methylene bridging is sterically controlled, and 
occurs most often between lysine and various other amino acids 
(arginine, cysteine, asparagine, glutamine). Except amino formylation, 
other bridgings are also possible (hydroxyls, indoles and imidazoles), 
but their stability is random. The lysine bindings with cysteine are 
relatively stable but reversible, those with arginine, asparagine and 
glutamine are stable but susceptible to acid hydrolysis, and those with 
tyrosine appear to be very stable and acid‐resistant. It seems in general 
that the stronger FA treatment is, the more acid‐resistant the binding, 
even if there is a variability among protein cross‐linkages.
These polymerization properties have been used in industrial 
applications. Bakelite (the first plastic) is the trademark name for FA 
and phenol polymer, formed under acidic conditions. As several 
embalming fluids combine both FA and phenol, this kind of 
polymerization may occur during thanatopraxy, but it is not clear 
whether these chemicals react within the fluid itself or within the corpse 
to form such a resin (Brenner, 2014). Another example is Formica, the 
trademark name for FA and urea polymer formed under neutral pH 
conditions. Formica is a resin used as glue, fire retardant and water 
repellant. As these resin formations can take place either using acid‐
catalysis (e.g. oxalic acid, hydrochloric acid or sulphonate acids) or 
base‐catalysis, such resin formation may take place when considering 
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the long storage‐times of the cadavers. When controlled, these reactions 
could positively contribute to the embalming, otherwise they could 
promote uncontrolled hardening and undesirable rigidity.
To avoid these reactions, FA is used in aqueous dilutions such as 
formaline. Formaline is constituted by 9–16% methanol, 33–49% FA 
and water up to 100%. Given the fact that a quantity of 4–5 g of FA is 
required to react with and fix 100 g of soluble protein and that the 
average protein content in the human body is about 16%, an 80‐kg body 
should contain about 13 kg of proteins requiring 0.5–0.6 kg of pure FA, 
i.e. 1.4–1.7 L of formaline (37% FA); (Mayer, 2012; Brenner, 2014). 
Based on an average amount of 10 L injected, the final FA 
concentration of the embalming fluid would be about 5–6%. Several 
formulations were developed with higher FA concentrations according 
to the aim of the fixation (educational tool, microscopic fixations, etc.) 
but, taking into account the toxicity of FA, the current formulations try 
to reduce FA amount (Coleman & Kogan, 1998; Tissier & Migné, 2001; 
Anderson, 2006; Levine et al. 2006; Whitehead & Savoia, 2008; 
Kalanjati et al. 2012; Gahukar et al. 2014). Indeed, an increase of FA 
amount in embalming fluids leads to an increase of free FA in body. 
This FA vapour needs to be evacuated before using the embalmed 
bodies as an educational tool before dissection (Keil et al. 2001; Sugata 
et al. 2016).
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FA as preservative
Formaldehyde is classified as a high level (8% FA in 70% alcohol) or 
intermediate‐to‐high level (4–8% FA in water) disinfectant (Mayer, 
2012). It has a broad spectrum of action on microorganisms, including 
putrefactive organisms. FA in solution constitutes by itself an aseptic 
medium for microbial growth. Furthermore, by reacting with proteins, it 
destroys the existing living organisms and forms new polymers (resins), 
which are stable and unfit as food for organisms. FA reacts with DNA 
less frequently than with RNA (single‐stranded DNA) because the 
hydrogen bonds holding DNA in its double helix are more stable 
(McKeen, 2012; Yamada et al. 2019). FA can bind covalently to 
adenine and guanine components of RNA and adenine, guanine and 
thymine of DNA to form cross‐links (stable methylene‐bis‐adenosine 
from adenine, for example) and with other protein to form molecular 
adducts unsuitable for life.
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As result, FA concentration should be sufficiently high to prevent 
microbial growth, but sufficiently low to avoid strong hardening and to 
prevent too much toxicity.
Indeed, if FA is toxic for putrefactive organisms, it is also toxic for 
humans working with it.
FA disadvantages
Formaldehyde solution (formaline) is considered a hazardous 
compound, notably by its toxic vapours. FA is rapidly metabolized, can 
be produced endogenously in humans or formed through the metabolism 
of many xenobiotic agents. At air levels of 0.5–2 ppm, FA may function 
as an irritant, and cause mild eye and mucous membrane irritations 
(Kim et al. 2011; Kundu & Gangrade, 2015; Kuriachan et al. 2017). 
Acute exposure to FA may reversibly diminish the sense of smell. 
Acute and chronic skin exposure may produce irritation and peeling, as 
well as an allergic contact dermatitis. Additionally to these pathological 
affections, an important variety of carcinomas have been associated 
with FA exposure, such as sinonasal, nasopharyngeal, other head and 
neck, respiratory cancer, lymphohaematopoietic, and brain and central 
nervous system cancers (Lu et al. 2010; Songur et al. 2010). FA was 
classified as a confirmed risk factor in cancer by the International 
Agency for Research on Cancer (IARC) in 2012 based on strong 
scientific evidence for sinonasal tumours, and more limited evidence for 
other tumours such as haematopoietic system (IARC Monographs, 
2012).
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In the anatomical context of the dissection laboratory, the adverse 
effects of FA have been studied extensively (Fritzsche et al. 2012; 
Gahukar et al. 2014; Arya et al. 2016; D'Ettorre et al. 2017; Elshaer & 
Mahmoud, 2017; Scheepers et al. 2018). Cytogenetic damages have also 
been reported in anatomy workers even below the respective 
occupational exposure limit (Bono et al. 2010; Musak et al. 2013; Costa 
et al. 2015). As a result, it was clearly put in evidence that FA can lead 
to important health issues, in the short term (skin and respiratory 
sensitization) and longer term (cancer).
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More extensive reviews about the biological effects and toxicity of FA 
are easily available in the literature (Patton, 2015; Zhang, 2018). Until 
now, there has been no ‘decision of non‐inclusion’ in Annex I or Ia of 
Directive 98/8/EC, for the relevant product‐type PT 22 ‘Embalming and 
taxidermist fluids’ revised in 2012 (EU Regulation 2012). However, EU 
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is aware that it is important to find substitution products to FA in this 
kind of fluids for both regulatory, safety and quality reasons (Technical 
notes for Guidance, 2013).
Besides toxicity and tissue hardening, FA has several other 
disadvantages for embalming purposes. It rapidly coagulates the blood, 
converts the tissues to grey when it mixes with blood, fixes 
discolourations, dehydrates tissues, constricts capillaries, deteriorates 
with age, and has an unpleasant odour. To counterbalance these 
inconveniences, FA‐based embalming fluid formulations were 
developed as aqueous dilutions with wetting agent and substances with 
strong diffusive physicochemical properties, such as glycerine, 
anticoagulant substances such as sodium citrate, dye such as eosin and, 
according to the case, specific additional solvent or products for precise 
goals such as colour control (use of chloral hydrate) or odour 
(perfumes; Mishra et al. 2016). However, the best formulation is 
difficult to achieve because each reagent is physicochemically different 
(solubility, viscosity, pH, ionic strength, behaviour in dilution, etc.).
In glycerine‐based formulations, ethanol or methanol must be added to 
inhibit microbial growth maintaining low FA concentration in 
embalming fluid, as glycerine has no antiseptic properties. Some 
formulations require pH buffering to avoid the inconveniences of a 
delayed acidification of the body over time, which could transform FA 
into formic acid. As time goes by, this kind of solution could generate 
skeletal decalcification and colour smoothing.
Another problem with the FA‐based embalming fluids can derive from 
the reaction with lipids, which is less described in literature (Jones, 
1969; Fox et al. 1985). FA reacts with the double bonds of unsaturated 
fatty acids. The resulting complex contains a free carbonyl group, 
which probably originates from the FA. The reaction occurs over a wide 
pH range, and takes place in the absence of oxygen or moisture. In this 
reaction, FA may act as an oxidizing agent, with production of aldehyde 
groups in the lipids, leading to physicochemical body changes during 
storage.
Therefore, the use of alcohols in FA‐based embalming fluids is practical 
for their germicide properties but also because alcohols can dissolve 
lipids (Demiryürek et al. 2002). According to the class of alcohols 
(primary, secondary or tertiary) and the dilution, the embalming fluid 
has different characteristics. The germicide effect is more important in 
heavy molecular weight alcohols so that methanol is less efficient than 
ethanol, and less efficient than isopropanol. The lipid extractive 
Page 8 sur 25
property is also related to the class of alcohols, and is more important in 
tertiary alcohols than primary alcohols. If the alcohols constitute 
satisfactory preservative agent, their tissue penetration is variable and 
they can contribute to tissue hardening in long‐term storage. As result, 
aqueous dilutions are necessary according to the embalming 
requirement. The mixture of alcohols and FA allows to combine the 
benefits of FA as tissue fixative and preservative with the benefits of 
alcohols (quick fixation, reduction of toxic FA vapours, better glycogen 
and nucleic acids preservation, etc.), and to limit the disadvantages of 
FA (toxicity, tissue hardening, etc.) and of pure alcohol‐based solutions 
(tissue shrinkage, hardening, deposition of pigment in blood, total or 
partial lysis of red blood cells, increased flammability, etc.; Cox et al. 
2006; Moelans et al. 2011; Shian et al. 2016).
Alternative to FA
Therefore, to avoid the inconveniences of FA‐based embalming fluids, 
trials have been performed and specific FA‐free formulations were 
commercialized to this purpose.
However, FA substitution must lead to similar final fluid properties and 
characteristics. As previously presented in Fig. 1, FA is a good 
preservative and fixative agent, active at neutral pH. It has an 
antimicrobial activity and tissue fixative properties, which must be 
controlled to avoid hardening. The use of another substance to 
guarantee the effects of FA must not destabilize the embalming fluid 
properties.
Consequently, metallic salts could be used as was done in the past, even 
if they also support a certain toxicity (Bryant & Peck, 2009; Hambly, 
2016). Zinc chloride (ZnCl ) could be useful as a preservative and 
penetrating agent, but should be used in mixture with moisturizing 
agents and dyes because, when used alone, it leads to rigidity and gives 
a grey hue to the body. Moreover, zinc chloride shows good tissue 
fixative properties (Van Toor et al. 2006; Goodarzi et al. 2017). 
However, it also has a significant toxicity for embalming operators 
(acidic pH, irritant to caustic agent) and may reduce the final 
compliance of the embalming fluid to the optimal embalming fluid 
properties. Aluminium sulphate [Al (SO ) ] could also be useful as an 
alternative due to its antimicrobial effect, but it is not soluble in water 
and has coagulant and tanning properties.
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Chloral hydrate [CCl CH(OH) ] is already used in embalming fluids, 
usually about 20% (w/w; Guimaraes da Silva et al. 2004). This 
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substance due to its carbonyl function acts as a preservative and tissue 
fixative, and prevents body discolouration. However, the best 
preservative agents are dialdehydes, such as glutaraldehyde, glyoxal, 
butanedialdehyde and ethanedial (Kiernan, 2000; Bedino, 2003; Balta 
et al. 2015; Cisne de Paula et al. 2018). Antimicrobial and fixative 
properties of dialdehydes mainly due to their carbonyl functions are 
distinct from their toxicities due to the number of carbon atoms 
separating the two carbonyl functions (dialdehyde with an even carbon 
atom number is less toxic than an odd number; Camiener, 1993; 
LoPachin & Gavin, 2014). Among them, glyoxal seems to be the best 
candidate for FA substitution.
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Other preservative substances have been investigated, such as 
diethylacetal [CH CH(C H O) ], formulated at 30–33% in mixture with 
tannins (7–9%) and potassium carbonate, such as salts/acids mixed with 
citric and ascorbic acids, and sodium and carbonate bisulphite 
formulated in equal parts in proportions up to 40% (Dessart et al. 2006), 
polyhexamethyleneguanidine hydrochloride (Anichkov et al. 2011), 
fluorine (Blake & Falder, 2004) or iodine derivatives such as 
polyvinylpyrrolidine‐iode (Dermot & Barrow, 2000) formulated in 
weak amounts (0.05–2%) with usual embalming fluids additives, or the 
use of N‐vinyl‐2‐pyrrolidone in dilution (from 4 to 21.5% of body 
weight; Haizuka et al. 2018). Other mixtures have also shown 
interesting properties to replace FA and phenol, such as ethanol
–glycerine–thymol mixture (Hammer et al. 2012), aliphatic alcohols‐
mono and diethylene glycols (Goyri‐O'Neill et al. 2013) or based on 
phenoxyethanol (Frolich et al. 1984).
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Other strategies could be developed based on vegetal tannins (tannic 
acid at levels from 1 to 10% in mixture with zinc and aluminium salts is 
used in wood preservation; Cisne et al. 2018), saturated salt solutions 
(Hayashi et al. 2014, 2016; Burns et al. 2018), sugars derivatives 
(oxopolysaccharides with free carbonyl functions) and honey (Sharquie 
& Najim, 2004; Kuriachan et al. 2017) , syntans (polymers of 
unsaturated carboxylic acids or their salts such as acrylic methacrylic, 
crotonic acids and acrylamide, acrylonitrile, etc. formulated from 3 to 
6%), resins such as polyacrylates (Kato et al. 2009; Fernandez, 2016) 
and polymethylacrylates (but their physicochemical properties remain 
different from those required for embalming fluid). Epoxy compounds 
have been also tested in concentrations close to 4%, and seem to lead to 
a weaker hardening and better life‐like colour than dialdehydes (Sung 
3 2 5 2
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et al. 1996; Alsharif et al. 2017; Ajileye et al. 2018). 1,4‐Bis
(hydroxymethyl)‐2,5‐piperazinedione (C H N O ) was also tested in 
embalming fluid for its biocid and preservative properties, but its price 
is consequent (Berke & Rosen, 1991). As result, if the individual 
properties of these substances seem very interesting for preservative 
and tissue fixative, their behaviour in mixture, their price and the 
intermediate reaction required to release FA are still not sufficiently 
controlled and optimized to imagine FA substitution.
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Finally, ionic liquids represent a very nice alternative (Dessart et al. 
2006). They are pure liquid organic salts at ambient temperature, and 
certain are composed with organic cations such as quaternary 
ammonium or imidazolium and aromatic or non‐aromatic compounds. 
These cheap and weakly toxic solvents have been tested in comparison 
to FA with very good results for 1‐methyl‐3‐octyl‐oxymethyl‐
imidazolium‐tetrafluoroborate for example (Majewski et al. 2003; 
Pernak et al. 2005). This opens up a wide field for future investigations 
on this new class of solvents in medicine by using them as a pure 
solvent or co‐solvent.
New alternative: FA‐releasers
FA‐releasers for embalming fluids
Formaldehyde‐releasers constitute a class of chemicals that are able to 
generate FA, directly through decomposition of a precursor already 
containing FA in its composition, or indirectly through reaction 
between reagents with FA as by‐product. There are over 30 FA‐
releasers with a wide array of applications (Table 1).
Table 1 List of FA‐releasers
Bioban CS 1135 Imidazolidinyl urea (IU)
Bioban CS 1246 MDM hydantoin
Bioban P‐1487 Methenamine
2‐Bromo‐2‐nitropropane‐1,3‐diol 
(Bronopol)
N,N′‐Methylenebis(5‐
methyloxazolidine)
Diazolidinyl urea (DU) 4,4′‐Methylenedimorpholine
6 10 2 4
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Dihydroxydimethylolethyleneurea, 
methylated N‐Methylol‐chloracetamide
1,3‐Dimethyl‐4,5‐dihydroxyethyleneurea Methylol urea
Dimethylhydantoin formaldehyde resin Paraformaldehyde
Dimethyloldihydroxyethyleneurea 
(DMDHEU) Polyoxymethylene melamine
Dimethylolethyleneurea Polyoxymethylene urea
Dimethylolpropyleneurea Benzylhemiformal/Preventol D2
Dimethylol urea Propyleneglycol hemiformal
DMDM hydantoin (DMDMH) Quaternium‐15 (Q‐15)
Ethylene urea Sodium hydroxymethylglycinate
Forcide 78  I Tetramethylol acetylenediurea
Forcide 78  II Tris(N‐hydroxyethyl)hexahydrotriazine
Glyoxalurea Tris(hydroxymethyl)‐nitromethane
Those that are in bold could be useful in embalming applications.
Only chemicals for which adequate clinical data are available to 
identify them as FA‐releasers beyond doubt have been compiled. Most 
are used as preservatives in cosmetics; as antimicrobials in 
metalworking fluids, paint, lacquers and varnishes; or as durable press 
chemical finishes in textiles (Flyvholm & Andersen, 1993). However, 
only a few of them could be used as suitable FA‐releasers in embalming 
fluids. Indeed, their FA‐releasing properties are strongly linked to pH. 
Most of them can liberate FA in acidic media, which have to be avoided 
in order to perform the best body perfusion during embalming.
AQ21
Formaldehyde‐releasing could constitute a positive approach to lower 
FA exposure for embalmers and thanatopraxy operators, but still 
guaranteeing the body preservation by FA. During embalming, FA is 
weakly present and the strategy is to permit FA‐release during the body 
storage. The main advantage is control FA emission over time, and the 
main drawback is the lack of data concerning the kinetics of FA release 
(Silverman & Holladay, 2015). Only six FA‐releasers have been 
investigated more deeply to understand the FA‐release kinetics: 2‐
®
®
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bromo‐2‐nitropropane‐1,3‐diol (Bronopol),
dimethyloldihydroxyethyleneurea (DMDHEU), DMDM hydantoin 
(DMDMH), dimethylol urea (DU), imidazolidinyl urea (IU) and 
quaternium‐15 (Q‐15; Fig. 2).
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Formaldehyde (FA) molecules produced from FA‐releasers.
Analytical challenge of FA measurement
Formaldehyde‐releasing has put in evidence an additional challenge to 
the analytical FA monitoring because both FA and FA‐releasers are 
chemically sensitive (SCCNFP, 2002). The parameters of the 
extraction/analysis method can induce biased results because FA release 
is driven by specific pH, temperature, ionic strength, dilution, and 
eventually the presence of other solvents or embalming fluid 
ingredients. The biochemical composition of the media is also of 
importance through cross‐linkages and reactions implying FA.
Indeed, the reactivity of FA constitutes a first problem. It has been 
shown using pure FA aqueous dilutions that the parameters of 
extraction and analysis can promote FA reactions with the matrix 
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compounds leading to an underestimated FA quantification. In a 
comparison between the free FA detected and the FA added of 1.0 g and 
0.5 g in water and in different cream bases, a higher percentage of free 
FA was detected from 0.5 g samples than from 1.0 g samples, whereas 
no correlation was seen between the viscosity of the cream base and the 
release of FA. As result, it seems that if the influence of the viscosity is 
not significant, only a part of FA released would be extracted and 
quantified. The other part of free FA may be still dissolved in the 
samples or may have reacted with other molecules as is the case with 
amino acids in amino formylation.
The second problem comes from the fact that FA release from FA‐
releasers is also chemically driven. Artificial FA release from FA‐
releasers can be observed during the extraction driven by specific 
conditions. As result, extraction and analytical procedures can induce a 
FA misestimation. It can be an overestimation when the analytical 
procedure promotes FA‐releasing or an underestimation when the 
physicochemical parameters promote FA‐releasers stability.
As result, new methods were developed to minimize the misestimation 
of FA amount due to extraction and analytical parameters. Indeed, the 
quantification of free FA in the presence of FA‐releasers usually gives 
too high and non‐reproducible values with the commonly applied 
methods, such as the ‘acetylacetone method’ and 2,4‐
dinitrophenylhydrazine (2,4‐DNPH) derivatization, as the FA‐releasers 
are degraded by the reagents in these methods (Brandao et al. 2018).
As the high‐performance liquid chromatography method with post‐
column derivatization adopted within the EU is too complicated for 
routine analysis, other extraction designs have been developed, such as 
gas‐diffusion microextraction with simultaneous acetylacetone 
derivatization, or closed container diffusion (CCD) method consisting 
of absorbent filter loaded with 2,4‐DNPH located in the headspace 
above the sample that must trap and derivatize free FA released from 
FA‐releasers present in the sample (Karlberg et al. 1998; Brandao et al. 
2018). Using these extraction methods, FA is gently trapped on 
absorbants minimizing artefactual reactions in the matrix. Then, FA is 
derivatized directly on these absorbants and later analysed.
FA‐releasing kinetics
For example, after 1 year of storage, cream base products fortified with 
various levels of FA‐releasers have led to the following average FA 
recovery yields, measured similarly with CCD and EU methods: 
DU = 15.9% (sample pH 4.4), IU = 8.5% (sample pH 4.4) and 
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Bronopol = 3.5% (sample pH 6; Karlberg et al. 1998). Other FA‐
releasing kinetics were done in aqueous samples with phosphate buffer 
(final buffer solution at 0.1 M at pH 7.4) and monitored by nuclear 
magnetic resonance (Kireche et al. 2010). Reactions between FA 
released and amino acids have been put in evidence, but free FA was 
still noticeable after several days of storage. Methenamine at 0.130, 
0.259 and 0.389 M has not led to a detectable amount of FA after 1 day 
of storage. This result is conformed to the fact that FA could be released 
from methenamine under acidic conditions and not at pH 7.4. With 
DMDMH, FA release was quick and the initial amount of FA‐releaser 
did not seem to be very influent even if a greater amount was obtained 
for the weakest concentration. Indeed, after 1 day of storage, about 31, 
24 and 21% of the theoretical amount of FA was generated, 
respectively, from DMDMH solutions at 0.096, 0.193 and 0.289 M at 
neutral pH. The polymerization of FA at highest concentrations could 
be a possibility to explain this result.
With Bronopol, from an aqueous dilution at 0.273 M, about 3.1, 3.7 and 
19% of the theoretical amount of FA was generated, respectively, after 
1, 7 and 40 days of storage. FA release from Bronopol was also more 
extensively investigated in other studies, but FA was analysed by 2,4‐
DNPH derivatization, a method known to overestimate FA release by 
degradation of FA‐releaser during the analysis (Kajimura et al. 2008). 
However, individual factors were investigated, such as pH, temperature 
and viscosity. Aqueous Bronopol solutions (0.1%, w/v) with 0.005 M
sodium phosphate buffer (pH 6) incubated for 90 min in water baths of 
25, 40 and 60 °C have resulted in temperature‐dependent FA release 
(Kajimura et al. 2008). The highest temperature led to the most 
important FA release. Aqueous Bronopol solutions (0.1 and 0.01% w/v) 
buffered at pH 2, 4, 6 and 8 with diluted 0.005 M sodium phosphate and 
stored 50 days at 25 °C resulted in pH‐dependent FA release. The 
alkaline pH led to the most important FA release. More precisely, a 
sharp increase of FA is noticed from the 1st to 3rd day, and a gradual 
increase from the 3rd to 50th day of storage. There was a corresponding 
decrease of Bronopol at these times but without pH changes. Finally, 
homemade lotion and jell formulated with two levels of Bronopol (0.1 
and 0.05%, w/v) have shown similar FA release at 25 °C over 50 days. 
However, and conversely to aqueous solutions, FA release from 
Bronopol in homemade cosmetics was not found to be pH dependent. 
These results suggest that FA release from Bronopol is also influenced 
by other matrix compounds. This information can be easily explained 
by the reaction of FA released and amino acids for example. The 
knowledge of the behaviour of FA‐releasers is crucial for further use in 
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the formulation of embalming fluids considering the complex 
composition of the human body.
As result, each FA‐releaser should be considered individually according 
to the required final characteristics of the formulated embalming fluid. 
Considering that a minimal amount of 4.5 g of FA is required to 
formulate 10 L of embalming fluid ready to be used, various amounts of 
FA‐releasers must be chosen to reach the same embalming properties of 
FA if added directly in the fluid. The FA‐release is matrix‐, pH‐, 
temperature‐ and quantity‐dependent (Doi et al. 2010). For example, if a 
body storage of 1 month is required and for a production of 10 L of 
embalming fluid, FA could be substituted by 50–60 g of DMDMH or 
minimal amount of 80 g of Bronopol if the pH is maintained at about 7 
if FA release is assumed to be linear. In case of more acidic pH 6 and 
for longer storage, a higher Bronopol amount would reach the required 
FA concentration. Alternatively, IU or DU could be used if pH was 
maintained even more acid (about 4), but this does not conform to the 
neutral pH usually required for good embalming practices. However, 
these suggestions should be very carefully investigated because some of 
them can lead to other problems. For example, Bronopol could 
decompose into nitrites, and in the presence of certain tertiary amines 
and amides can form carcinogenic nitrosamines (Balta et al. 2015).
Conclusion
Formaldehyde has been widely used in thanatopraxy and histology 
practices for centuries. It has the best compromise in terms of 
preservation, tissue fixative and desiccative retardant properties. 
However, this compound reveals an important toxicity, and is concerned 
by environmental and regulatory pressures in order to find an 
alternative. Potential candidates could be found through technology 
transfer from the tanning industry, for example. However, complete 
substitution of FA by other compounds has led to mixed results. 
Another alternative should be the use of FA‐releasers in embalming 
fluid formulations. These compounds can release FA over time, but they 
require the control of several parameters such as pH and temperature. 
However, they open new investigation routes to develop embalming 
fluids in order to guarantee the preservation and the safety of embalmed 
bodies as well as the life‐like aspect of dead bodies for grieving 
families and relatives.
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 Figure 1. Properties and characteristics of embalming fluid  
  
 
 
Figure 2. Formaldehyde molecules produced from formaldehyde releasers 
